Galectin-9 ameliorates fulminant liver injury
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Medicine Reports"
DOI: 10.3892/mmr.2017.6606
Abstract: Fulminant hepatitis is a severe liver disease resulting in hepatocyte necrosis. Galectin-9 (Gal-9) is a tandem-repeat-type galectin that has been evaluated as a potential therapeutic agent for various diseases that regulate the host immune system.… read more here.
Keywords: galectin; hepatitis; effects gal; liver injury ... See more keywords